Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED90 of oliceridine combined with propofol for pediatric upper gastrointestinal endoscopy
ChiCTR2400089415Phase 4Not yet recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oliceridine and propofol in None (2 arms), sponsored by Shanghai Children's Medical Center. Primary endpoint: Success rate of endoscope insertion. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
oliceridinepropofol
Beyond the preview
Go deeper on ChiCTR2400089415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089415.